Groundbreaking study shows adult stem cells have same ability to self-renew as embryonic

June 23, 2005

PITTSBURGH - June 23, 2005 - In a ground-breaking study, scientists at Children's Hospital of Pittsburgh have discovered that adult, or post-natal, stem cells have the same ability as embryonic stem cells to multiply, a previously unknown characteristic indicating that post-natal stem cells may play an important therapeutic role.

Adult and post-natal stem cells are often overlooked in favor of embryonic stem cells in the national debate over the therapeutic use of stem cells. Until now, it has been generally believed that embryonic stem cells had a greater capacity to multiply than post-natal stem cells, making them more desirable to research as a potential treatment, according to Johnny Huard, PhD, director of the Growth and Development Laboratory at Children's Hospital of Pittsburgh.

"Scientists have typically believed that adult or post-natal stem cells grow old and die much sooner than embryonic stem cells, but this study demonstrates that is not the case," said Dr. Huard, senior author of the study. "The entire world is closely following the advances in stem cell research, and everyone is interested in the potential of stem cells to treat everything from diabetes to Parkinson's disease. But there are also many ethical concerns surrounding the use of embryonic stem cells, concerns that you don't have with post-natal or adult stem cells. My belief is that this study should erase doubts scientists may have had about the potential effectiveness of post-natal stem cells."

Researchers from Children's and the University of Pittsburgh in Dr. Huard's laboratory were able to expand post-natal stem cells to a population level comparable to that reached by researchers using embryonic stem cells. Previous research has found that embryonic stem cells could undergo more than 200 population doublings before the cells began to die. A population doubling is a method of measuring the age of a population of cells.

Bridget Deasy, PhD, a scientist in Dr. Huard's laboratory, was first author of the study. Dr. Deasy, a research assistant professor in the Department of Orthopaedic Surgery at the University of Pittsburgh School of Medicine, discovered that a unique population of muscle-derived stem cells was able to undergo more than 200 population doublings, as well. These post-natal cells were able to undergo population doublings while maintaining their ability to regenerate muscle in an animal model, a key finding indicating that they could maintain their treatment potential.

This ability to self-replenish is significant because in order for stem cells to be used for treatment, a large quantity of the cells would be required.

The findings are published in the July 1, 2005, issue of Molecular Biology of the Cell, published by the American Society for Cell Biology. The paper is under consideration for Molecular Biology of Cell paper of the year.

There also may be important advantages to post-natal stem cells when it comes to autoimmunity, according to Dr. Huard, deputy director of the McGowan Institute of Regenerative Medicine and associate professor of Orthopaedic Surgery, Molecular Genetics and Biochemistry, and Bioengineering at the University of Pittsburgh School of Medicine.

The use of embryonic stem cells could be complicated by issues of rejection, with the recipient's immune system rejecting the foreign embryonic stem cells. With post-natal stem cells taken from the recipient and then reintroduced in an autologous manner, rejection would not be an issue.

Dr. Huard is one of the world's top cell biologists researching the potential therapeutic use of stem cells. He currently is working with the stem cells he discovered while searching for a cure for Duchene muscular dystrophy (DMD), a genetic disease that is estimated to affect one in every 3,500 boys. DMD is the most common form of muscular dystrophy affecting children and patients often die in early adulthood because of heart damage.

In addition to searching for a cure for DMD, Dr. Huard's laboratory also is researching the use of stem cells to repair injured muscle following sports-related injuries, as well as to treat cardiac, joint and bone injuries. His work with these stem cells has potential implications ranging from repairing heart muscle damaged by heart attack or disease to the prevention of rejection during organ and tissue transplantation.
-end-
The study was supported by the Muscular Dystrophy Association, the National Institutes of Health, the William F. and Jean W. Donaldson Chair at Children's Hospital of Pittsburgh and the Henry J. Mankin Chair at the University of Pittsburgh.

For more information on Dr. Huard's research and Children's, please visit the hospital's Web site at www.chp.edu.

Children's Hospital of Pittsburgh

Related Stem Cells Articles from Brightsurf:

SUTD researchers create heart cells from stem cells using 3D printing
SUTD researchers 3D printed a micro-scaled physical device to demonstrate a new level of control in the directed differentiation of stem cells, enhancing the production of cardiomyocytes.

More selective elimination of leukemia stem cells and blood stem cells
Hematopoietic stem cells from a healthy donor can help patients suffering from acute leukemia.

Computer simulations visualize how DNA is recognized to convert cells into stem cells
Researchers of the Hubrecht Institute (KNAW - The Netherlands) and the Max Planck Institute in Münster (Germany) have revealed how an essential protein helps to activate genomic DNA during the conversion of regular adult human cells into stem cells.

First events in stem cells becoming specialized cells needed for organ development
Cell biologists at the University of Toronto shed light on the very first step stem cells go through to turn into the specialized cells that make up organs.

Surprising research result: All immature cells can develop into stem cells
New sensational study conducted at the University of Copenhagen disproves traditional knowledge of stem cell development.

The development of brain stem cells into new nerve cells and why this can lead to cancer
Stem cells are true Jacks-of-all-trades of our bodies, as they can turn into the many different cell types of all organs.

Healthy blood stem cells have as many DNA mutations as leukemic cells
Researchers from the Princess Máxima Center for Pediatric Oncology have shown that the number of mutations in healthy and leukemic blood stem cells does not differ.

New method grows brain cells from stem cells quickly and efficiently
Researchers at Lund University in Sweden have developed a faster method to generate functional brain cells, called astrocytes, from embryonic stem cells.

NUS researchers confine mature cells to turn them into stem cells
Recent research led by Professor G.V. Shivashankar of the Mechanobiology Institute at the National University of Singapore and the FIRC Institute of Molecular Oncology in Italy, has revealed that mature cells can be reprogrammed into re-deployable stem cells without direct genetic modification -- by confining them to a defined geometric space for an extended period of time.

Researchers develop a new method for turning skin cells into pluripotent stem cells
Researchers at the University of Helsinki, Finland, and Karolinska Institutet, Sweden, have for the first time succeeded in converting human skin cells into pluripotent stem cells by activating the cell's own genes.

Read More: Stem Cells News and Stem Cells Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.